02Progress Photos and Journey Cards Some weeks the scale stalls
CA7S lowers blood glucose by inducing glucagon-like-peptide-1 (GLP-1) secretion in the gut
To view a copy of this license, visit About this article Cite this article Coelho, C., Dobbie, L.J., Crane, J
A possible interaction between apo C-II deficiency and apo E4 in a severely hypertriglyceridemic patient
10.2337/dc19-0898 Summary Keywords GLP-1 receptor agonists, type 2 diabetes mellitus, gastrointestinal adverse events, Bayesian network meta-analysis, nausea, vomiting, diarrhea Citation Xie X, Yang S, Deng S, Liu Y, Xu Z and He B (2025) Comparative gastrointestinal adverse effects of GLP-1 receptor agonists and multi-target analogs in type 2 diabetes: a Bayesian network meta-analysis
This can be particularly beneficial after fat-dissolving treatments, as it helps prevent sagging skin that may occur as fat cells are reduced